Immuron (IMRN) Restructuring Costs (2016 - 2017)
Immuron's (IMRN) quarterly Restructuring Costs came in at -$646853.5 in Q4 2017, down 8.58% year-on-year from -$707589.0 in Q4 2016, and down 8.58% quarter-over-quarter from -$595720.3 in Q4 2016.
Immuron (IMRN) Restructuring Costs (2016 - 2017) Analysis & Trends
Immuron's Restructuring Costs history runs 2 years deep, the most recent figure standing at -$646853.5 for Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Immuron | 255.19 Mn | 243.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | -646,853.55 |
| Dec 31, 2016 | -595,720.30 |
| Jun 30, 2016 | -986,072.81 |